RhumbLine Advisers’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.8K Hold
3,766
﹤0.01% 3767
2025
Q4
$11.1K Buy
3,766
+552
+17% +$1.51K ﹤0.01% 3838
2025
Q3
$7.78K Sell
3,214
-980
-23% -$3.14K ﹤0.01% 3879
2025
Q2
$13.8K Sell
4,194
-866
-17% -$3.14K ﹤0.01% 3836
2025
Q1
$19.5K Sell
5,060
-21
-0.4% -$87 ﹤0.01% 3744
2024
Q4
$19.6K Hold
5,081
﹤0.01% 3804
2024
Q3
$37.3K Sell
5,081
-90
-2% -$590 ﹤0.01% 3733
2024
Q2
$33.4K Sell
5,171
-560
-10% -$4.46K ﹤0.01% 3785
2024
Q1
$60.3K Hold
5,731
﹤0.01% 3586
2023
Q4
$50.5K Buy
5,731
+650
+13% +$4.96K ﹤0.01% 3632
2023
Q3
$41.7K Buy
5,081
+85
+2% +$823 ﹤0.01% 3683
2023
Q2
$58.2K Buy
+4,996
New +$47.3K ﹤0.01% 3648

Other funds holding BAK

RhumbLine Advisers's BAK Position: Q1 2026 in Review

RhumbLine Advisers held its Braskem (BAK) position steady in Q1 2026 at 3,766 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3767.

RhumbLine Advisers first reported a position in BAK in Q2 2023 and has held it in 12 quarters since. The position peaked at $60.3K in Q1 2024. 64 funds tracked by Wall St. Rank hold BAK as of Q1 2026.

  • RhumbLine Advisers held 3,766 shares of Braskem worth $13.8K as of Q1 2026.
  • RhumbLine Advisers left its Braskem share count unchanged in Q1 2026.
  • Braskem made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #3767 holding.
  • RhumbLine Advisers first reported a position in Braskem in Q2 2023 and has held it in 12 quarters since.
  • RhumbLine Advisers's Braskem position peaked at $60.3K in Q1 2024.
  • 64 funds tracked by Wall St. Rank held Braskem as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.